Latest News

George Clinical, leading Asia-Pacific CRO, expands into US with acquisition of a specialised oncology CRO Division

Sydney, Australia (May 2, 2017) – George Clinical, a leading full-service CRO in the Asia-Pacific region and Vector Oncology, a Memphis-based leader in oncology research and data analytics, formally announced today that George Clinical has acquired Vector Oncology’s CRO Division. Effective immediately, the transaction has the dual purpose of strengthening the ability of George Clinical […]

Read More

May 3rd, 2017
Hong Kong

Hong Kong Wholesale Dealer Licence

George Clinical is pleased to announce the receipt of their Hong Kong Wholesale Dealer licence issued by the Department of Health on the 3rd April. This licence represents a significant step forward in George Clinical’s operations in Hong Kong, allowing them to apply for a Certificate of Clinical Trial on behalf of the sponsor and […]

Read More

May 2nd, 2017

Taiwan: The Clinical Trials Gateway to China?

Taiwan sits, along with its smaller counterparts, Singapore and Hong Kong, as one of the gateway countries to running a clinical trial in China. Although Hong Kong’s regulatory ties are more formalized with China, than Taiwan, Taiwan has the right environment and population to make the possibility of greater regulatory cohesion with its giant neighbour, […]

Read More

March 15th, 2017
south korea

South Korea: A Top Clinical Trial Destination

Clinical trial sponsors and CROs don’t need to imagine South Korea as a country of limitless potential, they know it is. South Korea is a clinical trial destination with world-class medical infrastructure, a highly-educated, relatively wealthy and healthy population. Their investigators are, on the whole, actively engaged in clinical trials and keen to play their […]

Read More

March 15th, 2017

International Women’s Day

As the world stops to celebrate and reflect on International Women’s Day on the 8th of March, George Clinical is proud to play their part in #beboldforchange. Traditionally the commercial research sector has a larger proportion of female practitioners than men. Indeed, at George Clinical, the proportion female to men at 158:73 and with a […]

Read More

March 9th, 2017
program and protocol design

George Clinical welcomes Kristina Figueroa and Mindy Farr to the George Clinical team

George Clinical is pleased to announce the continued expansion of their Business Development operations in the US, with the recent appointments of Mindy Farr as Senior Business Development Manager and Kristina Figueroa, Business Development Manager. “Both Mindy and Kristina are joining George Clinical at an exciting time in the organisation’s history”, Mr Clark said. “We […]

Read More

February 3rd, 2017

The George Institute – Winners of the Google Impact Challenge

Video Transcript Congratulations on The Google Impact Challenge win. Can you explain what TEXTCARE does and what issue it addresses? 0:07 – 3:09 It is really exciting; I think we’re all a little bit stunned still, although I feel that we did have a fabulous proposal and it’s very exciting to think that we will […]

Read More

January 20th, 2017

Wearables are Improving Clinical Trial Research

The face of individual health care is changing and improving, thanks to wearables. Wearable health and fitness devices are becoming more popular by the day and with our mobile devices and wearables prompting us to keep up with good health habits, overall health is improving too. As individuals are more aware of their health, more […]

Read More

January 12th, 2017

Wearables set to impact all areas of healthcare including clinical trials

With the New Year comes new innovations in technology. Many new technological innovations were just announced and launched at the Consumer Electronics Show (CES) in Las Vegas earlier this month. Normally this is not big news for the healthcare industry, or in the area of clinical trials, but this year was an exception. Some very […]

Read More

January 10th, 2017

Which clinical trials need a Clinical Endpoint Adjudication Committee?

Increasingly, regulatory authorities are placing significant focus on clinical trial processes that ensure consistent, standardized, objective and unbiased reporting of safety and efficacy results; given that the definitions for many endpoint events include subjective components, and investigator-to-investigator subjective assessments may differ. Moreover, an increasing number of trials are now conducted in multiple geographies, and clinical […]

Read More

January 8th, 2017

Join our Mailing List

Add George Clinical to your network